| AE |
Placebo
(n=211) |
Olodaterol 5 µg
(n=216) |
Olodaterol 10 µg
(n=214) |
Tiotropium 18 µg
(n=214) |
| Any AE, n (%) |
72 (34.1) |
73 (33.8) |
78 (36.4) |
73 (34.1) |
| Nasopharyngitis |
12 (5.7) |
14 (6.5) |
8 (3.7) |
11 (5.1) |
| COPD |
10 (4.7) |
14 (6.5) |
9 (4.2) |
6 (2.8) |
| Dyspnea |
5 (2.4) |
5 (2.3) |
5 (2.3) |
6 (2.8) |
| Cough |
6 (2.8) |
1 (0.5) |
7 (3.3) |
5 (2.3) |
| Headache |
4 (1.9) |
4 (1.9) |
2 (0.9) |
3 (1.4) |
| Hypertension |
2 (0.9) |
2 (0.9) |
2 (0.9) |
2 (0.9) |
| Back pain |
3 (1.4) |
2 (0.9) |
0 |
3 (1.4) |
|
